This approach enhances the ability of infiltrating T cells to recognize tumor cells by inhibiting the programmed cell death protein-1 (PD-1)/programmed cell death protein ligand-1 (PD-L1) axis.14 This evidence concerns the gene PDCD1 and neoplasm.